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Neural circuit activity increases the release of the purine neuromodulator adenosine
into the extracellular space leading to A1 receptor activation and negative feedback
via membrane hyperpolarization and inhibition of transmitter release. Adenosine can
be released by a number of different mechanisms that include Ca2+ dependent
processes such as the exocytosis of ATP. During sustained pathological network activity,
ischemia and hypoxia the extracellular concentration of calcium ions (Ca2+) markedly
falls, inhibiting exocytosis and potentially reducing adenosine release. However it
has been observed that reducing extracellular Ca2+ can induce paradoxical neural
activity and can also increase adenosine release. Here we have investigated adenosine
signaling and release mechanisms that occur when extracellular Ca2+ is removed.
Using electrophysiology and microelectrode biosensor measurements we have found
that adenosine is directly released into the extracellular space by the removal of
extracellular Ca2+ and controls the induced neural activity via A1 receptor-mediated
membrane potential hyperpolarization. Following Ca2+ removal, adenosine is released
via equilibrative nucleoside transporters (ENTs), which when blocked leads to hyper-
excitation. We propose that sustained action potential firing following Ca2+ removal
leads to hydrolysis of ATP and a build-up of intracellular adenosine which then effluxes
into the extracellular space via ENTs.
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INTRODUCTION
The purine adenosine is a potent neuromodulator involved in many physiological and pathological
processes (reviewed in Dunwiddie and Masino, 2001; Sebastião and Ribeiro, 2009; Borea et al.,
2016). Adenosine acts via multiple subtypes of cell-surface G-protein-coupled receptors, with
the high-affinity inhibitory A1 receptor the most widely expressed (reviewed in Fredholm
et al., 2000). In the hippocampus activation of A1 receptors inhibits glutamatergic synaptic
transmission and hyperpolarizes the membrane potential of pyramidal cells (Dunwiddie and
Fredholm, 1989; Thompson et al., 1992). Adenosine is released during epileptiform activity
both in vivo (measured with microdialysis) and in vitro (induced by removal of Mg2+; measured
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with biosensors) where it provides negative feedback to
terminate bursts and delay the next burst of activity
(During and Spencer, 1992; Dale and Frenguelli, 2009;
Boison, 2015; Wall and Richardson, 2015). The activity-
dependent release of adenosine into the extracellular space
can occur through multiple mechanisms (reviewed in Wall
and Dale, 2008) which include direct release of adenosine
via equilbrative nucleoside transporters (ENTs; Lovatt
et al., 2012; Wall and Dale, 2013) and indirect release as
ATP by exocytosis from neurons (Pankratov et al., 2007)
or glial cells (Newman, 2004; Pascual et al., 2005; Wall
and Dale, 2013) to be metabolized to adenosine in the
extracellular space. There is also evidence that adenosine
can be released directly by exocytosis in the cerebellum
(Klyuch et al., 2012). In the hippocampus, it appears
that activity-dependent adenosine release occurs via a
combination of different mechanisms which include exocytosis
of ATP and transporter-mediated release (Wall and Dale,
2013).
During sustained pathological neural activity (Heinemann
et al., 1977, 1981; Somjen and Giacchino, 1985), ischemia
(Hansen and Zeuthen, 1981) and hypoxia (Silver and Ereci´nska,
1990) the extracellular concentration of calcium ions (Ca2+)
is dramatically reduced. It is unclear what happens to
adenosine signaling under these conditions, but since some
of the adenosine release mechanisms are Ca2+ dependent, it
would be predicted that adenosine release would also fall.
However, it has been observed that removing extracellular Ca2+
actually enhances the amount of adenosine released during
ischemia (Pedata et al., 1993; Frenguelli et al., 2007) and
hypoxia (Dale et al., 2000) in the hippocampus, measured
with HPLC and with biosensors. The mechanism for these
increases in adenosine release are unclear but they maybe
a consequence of the production of a paradoxical form
of neural activity induced by Ca2+ removal. This neural
activity can be observed in the hippocampus both in vitro
(Haas and Jefferys, 1984; Konnerth et al., 1986; Agopyan
and Avoli, 1988; Bikson et al., 1999) and in vivo (Feng,
2003). The mechanisms that increase neural excitability and
synchrony are not fully understood but have been attributed
to a number of processes including: reduced surface charge
screening at the cell membrane (Frankenhaeuser and Hodgkin,
1957), inhibition of Ca2+-dependent K+ channels (Lancaster
and Nicoll, 1987); reduced synaptic activation of GABAergic
inhibitory interneurons (Bikson et al., 1999); electrical coupling
via gap junctions (Perez-Velazquez et al., 1994) and extracellular
electric-field effects (ephaptic transmission, Zhang et al.,
2014). Removal of extracellular Ca2+ also enhances the
opening of ion channels such as voltage-gated Na+ channels
(Armstrong and Cota, 1999) and produces transient increases in
extracellular K+ concentration that can facilitate the propagation
of field bursts (Bikson et al., 2002). Here we have used
biosensors and electrophysiology, to directly define what
happens to adenosine signaling when extracellular Ca2+ is
removed and to determine whether adenosine signaling plays
a role in controlling the neural activity induced by Ca2+
removal.
MATERIALS AND METHODS
Preparation of Hippocampal Slices
Sagittal slices of hippocampus (300–400 µm) were prepared
from male Sprague-Dawley rats, at postnatal days 18–30. In
accordance with the U.K. Animals (Scientific Procedures) Act
(1986) rats were killed by cervical dislocation and decapitated.
Hippocampal slices were cut with a Microm HM 650V
Microslicer in cold (2–4◦C) high Mg2+, low Ca2+ aCSF,
composed of (mM): 127 NaCl, 1.9 KCl, 8 MgCl2, 0.5 CaCl2,
1.2 KH2PO4, 26 NaHCO3, 10 D-glucose (pH 7.4 when bubbled
with 95% O2 and 5% CO2). Slices were stored at 34◦C for
1–6 h in standard aCSF (127 NaCl, 1.9 KCl, 1 MgCl2, 2 CaCl2,
1.2 KH2PO4, 26 NaHCO3, 10 D-glucose). This study was
carried out in accordance with the recommendations of the U.K.
Animals (Scientific Procedures) Act (1986). All experiments were
approved by the local Animal Welfare and Ethics Board at the
University of Warwick (AWERB).
Extracellular and Biosensor Recording
from Hippocampal Slices
A slice was transferred to the recording chamber, submerged
in aCSF and perfused at 6 ml/min (32◦C). For extracellular
recording, an aCSF-filled microelectrode was placed on the
surface of stratum pyramidale in CA1. Extracellular recordings
were made using a differential model 3000 amplifier (AM
systems, Sequim, WA, USA). Signals were filtered at 3 kHz and
digitized on line (10 kHz) with a Micro CED (Mark 2) interface
controlled by Spike software (version 6.1, Cambridge Electronic
Design, Cambridge, UK). Standard cylindrical microelectrode
biosensors (50 µm diameter, Sarrisa Biomedical, Coventry, UK)
were inserted into the slice in CA1 (Wall and Dale, 2013).
Biosensor signals were acquired at 1 kHz with a Micro CED
(Mark 2) interface using Spike (version 6.1) software. Zero Ca2+
aCSF consisted of standard aCSF with no Ca2+, 1 mM Mg2+
and 1 mM EGTA. For the experiments where high K+ aCSF was
puffed onto area CA1 in the hippocampus, the high K+ aCSF
had the same composition as zero Ca2+ aCSF but the total K+
concentration was elevated to 10–25 mM with KCl.
Biosensor Characteristics
Biosensors (Sarissa Biomedical Ltd., Coventry, UK) consist of
enzymes trapped within a matrix around a Pt or Pt/Ir (90/10)
wire (Llaudet et al., 2003). Biosensors are cylindrical, and have
an exposed length of ∼500 µm and diameter of ∼50 µm.
Four types of sensor were used: null sensors, possessing
the matrix but no enzymes, to control for non-specific
electro-active interferents; biosensors containing adenosine
deaminase, nucleoside phosphorylase and xanthine oxidase
(responsive to adenosine, inosine and hypoxanthine: ADO
biosensors); biosensors containing nucleoside phosphorylase
and xanthine oxidase (responsive to adenosine metabolites
inosine and hypoxanthine: INO biosensors); and finally
ATP biosensors which consist of the entrapped enzymes
glycerol kinase and glycerol-3-phosphate oxidase (Llaudet
et al., 2005). Glycerol (2 mM) was included in the aCSF
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for experiments measuring ATP release, as glycerol is
required as a co-substrate for ATP detection (Llaudet et al.,
2005).
Biosensors show a linear response to increasing
concentrations of analyte and respond rapidly (<1 s, Llaudet
et al., 2003, 2005; Wall and Richardson, 2015; see Frenguelli
and Wall, 2016 for a review of biosensor measurements
in models of epilepsy). The lower limit of detection for
adenosine biosensors is ∼30–60 nM which would give a
current of ∼5–10 pA. Biosensors were calibrated with known
concentrations (10 µM) of adenosine, inosine and ATP. To
test the integrity of the screening layer 5-HT (10 µM) was
applied. In many experiments, the composition of purines
detected by ADO biosensors was not fully defined. Since ADO
biosensors have an equal sensitivity to adenosine, inosine
and hypoxanthine (Llaudet et al., 2003; Wall et al., 2007) the
total concentration of purines detected was referenced to the
calibration to adenosine to give µM or nM of purines. None of
the drugs used in this study (8-cyclopentyltheophylline (8-CPT),
6-[(4-nitrobenzylothiol]-9-b-D-ribofuranosylpurine (NBTI) and
dipyridamole) had any effects on biosensor sensitivity or the
baseline current.
Deconvolution and Reconvolution
of Purine Waveforms
The amplitude of closely spaced waveforms produced by the
release of adenosine can be difficult to measure accurately as
subsequent pulses sit on the decay of proceeding ones. Following
(Richardson and Silberberg, 2008), closely space release-events
were deconvolved as inWall and Richardson (2015) by removing
the long decay τo component. The resulting sharper, well-spaced
events were then cropped and reconvolved to yield isolated
waveforms from which the amplitude and rise time could
be accurately measured. All analysis was done in the JULIA
programming environment.
Whole-Cell Patch Clamp Recording
from Pyramidal Cells
A slice was transferred to the recording chamber and perfused at
3 ml min−1 with aCSF at 32± 0.5◦C. Slices were visualized using
IR-DIC optics with a SliceScope (Scientifica) and a CCD camera
(Scientifica, Bedford, UK). Whole-cell current clamp recordings
were made from single or pairs of pyramidal cells in area CA1 of
the hippocampus using patch pipettes (5–10 MΩ) manufactured
from thick walled glass (Harvard Apparatus, Edenbridge, UK)
and containing (mM): potassium gluconate 135, NaCl 7,
HEPES 10, EGTA 0.5, phosphocreatine 10, MgATP 2, NaGTP
0.3 and biocytin 1 mg ml−1 (290 mOsm, pH 7.2). Voltage
recordings were obtained using an Axon Multiclamp 700B
amplifier (Molecular Devices, USA) and digitized at 20 kHz.
Data acquisition and analysis was performed using Pclamp 10
(Molecular Devices). If the series resistance exceeded 14 mΩ
than recordings were aborted, the mean series resistance was
11.2 ± 0.2 mΩ (n = 30). The standard I-V relationship was
obtained by injecting step currents starting between −400 pA
and −300 pA, incrementing by 100 pA until a regular firing
pattern was induced. A plot of step current against average
voltage response (measured at steady state after the activation
of IH) around the resting potential was used to measure the
input resistance (gradient of fitted line; as in Kaufmann et al.,
2016).
Drugs and Substances
All drugs were made up as 10–100 mM stock solutions, stored
frozen and then thawed and diluted with aCSF on the day of use.
Adenosine, inosine, 5 HT, dipyridamole, NBTI and 8-CPT were
purchased from Sigma (Dorset, UK). ATP was purchased from
Roche (Indianapolis, IN, USA). All substances were dissolved in
distilled water except NBTI which was dissolved in DMSO (final
concentration of DMSO in aCSF was 0.05%, which had no effect
on biosensor or tissue responses).
RESULTS
Characterization of Hippocampal Activity
Induced by Removal of Ca2+
Before assessing any adenosine release following the removal
of extracellular Ca2+, we first characterized the neural activity
produced when extracellular Ca2+ was removed.We investigated
early changes in activity (0–1 h) following perfusion with zero-
Ca2+ aCSF (zero Ca2+, 1 mM Mg2+ and 1 mM EGTA),
unlike some previous studies where activity was measured
1–2 h after Ca2+ removal (Haas and Jefferys, 1984; Bikson
et al., 1999). Whole-cell patch recordings were made from
CA1 pyramidal cells in hippocampal slices (30 cells). This
includes paired recordings (five pairs) so we could measure the
homogeneity of activity across the network. Following perfusion
with zero-Ca2+ aCSF pyramidal cells typically showed a pattern
of initial depolarization (2–7 mV, mean membrane potential
−58.5 ± 3 mV) with the firing of single action potentials at
∼4–8 Hz (Figure 1A, cell 1 as previously reported in Konnerth
et al., 1986). This was followed by a recovery of the membrane
potential back to a value close to that observed at rest (after
5–10 min, mean resting potential −65 ± 2 mV), interrupted
with short membrane potential depolarizations (∼3–6mV,mean
depolarization 5.4 ± 0.5 mV occurring at a frequency between
2 Hz and 5 Hz) and superimposed bursts of action potentials
(Figure 1A as previously described in Konnerth et al., 1986;
Bikson et al., 2002). The precise profile of activity varied between
recordings with some cells going straight into this phase, some
cells remaining depolarized (Figure 1A, cell 2) and in some
cells the membrane potential becoming hyperpolarized below
that observed at rest with no action potential firing. Recordings
from pairs of cells in the same field of view but not adjacent,
showed that cells had individual patterns of activity (Figure 1A).
This pattern of activity was often accompanied by occasional
depolarizing shifts in the membrane potential (observed in
26 out of 30 recordings) which could be large enough to
push the cell into depolarization block (Figure 1A, cell 2,
Figures 1B–D). These depolarizations have been associated with
waves of increased extracellular K+ observed with prolonged
Ca2+ removal (over 1 h; Bikson et al., 2003) and could last for
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a few seconds to several minutes before the membrane potential
hyperpolarized and the cell began firing again (Figure 1C).
From paired recordings, it was found that these events could
be localized (for example only observed in cell 2, Figure 1A)
or could be synchronized (observed in both cells Figure 1B).
In many recordings strong bursts of activity were followed by
a prolonged membrane potential hyperpolarization (Figure 1D,
mean duration 45 ± 10 s, n = 10). When the extracellular Ca2+
was washed back in, even after prolonged periods of activity
(up to an hour), most pyramidal cells had resting membrane
potentials (−71 ± 3 vs. −67 ± 7 mV) and IV relationships
(steady state input resistance 121 ± 15 vs. 115 ± 13 mΩ) which
were not significantly different to that observed at the start of
the recording. Thus the removal of extracellular Ca2+ did not
induce irreversible changes in pyramidal cell properties. Some
recordings were lost before the return of extracellular Ca2+, data
from these cells is included in our analysis.
Endogenous Activation of A1 Receptors
Controls Ca2+-Free Activity
To assess whether endogenous activation of adenosine A1
receptors plays a role in controlling the activity induced by
Ca2+ removal, the A1 receptor antagonist 8CPT (2 µM) was
applied to slices. Application of 8CPT markedly depolarized the
membrane potential (17.5 ± 3.5 mV, n = 8) and produced a
significant increase in the action potential firing rate (Figure 2A).
In some cells, this depolarization was followed by an irreversible
depolarizing shift of the membrane potential and in other cells
8CPT immediately induced a depolarizing block (Figure 2B).
Therefore endogenous activation of A1 receptors plays a key
role in limiting Ca2+-free activity. In contrast, blocking A1
receptors in control aCSF had little or no effect on the resting
potential of pyramidal cells (2 ± 0.5 mV, n = 5, Figure 2C)
showing that when the network is quiescent there is little
A1 receptor activation (in agreement with previous studies;
Thompson et al., 1992). We therefore hypothesize that Ca2+-
free-induced activity increases the extracellular concentration of
adenosine leading to A1 receptor activation which feeds back to
suppress activity.
Extracellular Adenosine Concentration
Is Increased in Ca2+ Free aCSF
Before using adenosine (ADO) biosensors to directly measure
any changes in the extracellular concentration of adenosine,
we first tested whether changing the ionic environment had
effects on the biosensor sensitivity to adenosine. Changing from
standard aCSF to zero Ca2+ aCSF had no significant effect on the
biosensor baseline or sensitivity to adenosine (Figure 3A) even
with prolonged incubation (30min). Thus biosensors can be used
to accurately measure changes in extracellular adenosine induced
by removal of Ca2+.
Biosensors were inserted into area CA1 of the hippocampus
and tissue was allowed to recover (20–30 min, see Figure 3B
for electrode arrangement). After application of Ca2+-free aCSF
a large current was induced on ADO biosensors (peak value
741 ± 185 pA, Figures 3C,D n = 15) which was absent on
null sensors and thus was due to the detection of purines
(current equivalent to a concentration of 4.6 ± 1 µM of
purines). This current had a number of distinct phases, which
were particularly evident when the ADO biosensor traces were
deconvolved and the phases were separated: there was an initial
increase in baseline current (1, on Figure 3B), this reached
an intermediate plateau (250 ± 50 pA, 1.8 ± 0.8 µM of
purines) and then there was a second slower rising increase in
purine concentration (2, on Figure 3B). This second component
reached a peak, began to decline and then entered a long-lived
third phase (3, on Figure 3B) that was often accompanied by
superimposed spontaneous increases in purine concentration
(arrows on Figure 3C). This third phase occurred at the
same time that pyramidal cells exhibited a pattern of short
membrane depolarizations and action potential firing. We used
differential measurements with ADO and INO biosensors to
determine whether adenosine or its metabolites were being
measured (Figure 3D). The initial currents (phases 1 and 2)
measured on ADO and INO biosensors were very similar in
amplitude and kinetics, with no clear differential signal visible
on the ADO biosensor, as would be expected if adenosine
was directly detected (Figure 3D; Wall and Richardson,
2015).
Spontaneous Purine Release Events Occur
during Established Ca2+-Free Activity
During established Ca2+-free activity (∼30 min in Ca2+ free
aCSF), spontaneous purine-release events were superimposed
on a sustained elevated extracellular purine concentration in
the majority of slices (9 out of 15, phase 3, Figures 4A–C).
These waveforms occurred at a frequency of one every 4–10 min
(mean interval between events 5.5 ± 4 min), amplitudes ranging
between 50–400 pA (equivalent to 0.2–1.5 µM of purines), a
10%–90% rise-time of 51 ± 4 s and a slow, exponential decay
(with a time constant ∼200 s, Figure 4A). To investigate the
spatial synchrony of these events across the slice, two biosensors
were placed in CA1 (either two ADO biosensors or an ADO
and INO biosensor), ∼0.5 mm apart, with an extracellular
electrode placed between them (as illustrated in Figure 3B).
Figure 4B shows spontaneous purine-release events measured
simultaneously (dotted lines) on both of the biosensors. It
is known that adenosine is rapidly diluted by diffusion: its
waveform is reduced to 1% of peak amplitude 100 µm away
from the release source (Wall and Richardson, 2015). As the
purine waveforms of similar amplitude are seen simultaneously
at the two biosensors (separated by 0.5 mm) this must therefore
reflect global release due to widespread, coordinated activity
across CA1, rather than diffusive spread of purine from a single
source. In contrast, in Figure 4C, the first three purine release
events are only detected on one of the biosensors (ADO) and
do not correlate with the activity on the extracellular electrode.
It therefore appears that in this slice adenosine released is
localized and occurs close to the ADO biosensor and this increase
in concentration is dissipated over the distance between the
biosensors. The final event (asterisk) is detected on both of the
biosensors and thus activity at this time may be co-ordinated
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FIGURE 1 | Characterization of Ca2+ free activity in the hippocampus. (A) Time-course of the effects of perfusing Ca2+-free aCSF (1 mM EGTA) on the activity
recorded simultaneously from two pyramidal cells in area CA1 of the hippocampus. Inset: illustrates when Ca2+-free aCSF first began to induce neural activity in
cell 1, and induces spontaneous events in cell 2 which maybe excitatory postsynaptic potentials (EPSPs). At 20 min, there are frequent short depolarizations with
superimposed action potentials, a single example of such an event is illustrated in the inset (action potentials are truncated). After ∼45 min there was a rapid
depolarizing shift in the membrane potential in cell 2 that was not observed in cell 1. (B) Recordings from a pair of pyramidal cells where there was a simultaneous
depolarization in both cells with a very similar time course. The top cell was active whereas the bottom cell was quiescent before the depolarization occurred.
(C) Example of a large rapid depolarizing shift in membrane potential leading to depolarization block. The membrane potential remained depolarized (at around
−16 mV) for ∼70 s, repolarized and the pyramidal cell resumed firing. (D) Following a strong burst of activity, a prolonged hyperpolarization occurred (starting at
arrow, duration ∼50 s, dotted line is the membrane potential before the burst of activity). In (D) action potentials are truncated at −40 mV and this recording was not
performed simultaneously with that in (C).
across the slice. This data suggests that purine release events
can be localized or can spread globally across CA1 presumably
co-ordinated by activity.
When release-events were detected on both ADO and INO
biosensors, we compared the rise of the signals to see if we
could separate components produced by adenosine and by its
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FIGURE 2 | Ca2+ free-activity is suppressed by adenosine A1 receptor activation. (A) Whole-cell recording from a pyramidal neuron during Ca2+-free activity
illustrating the effect of blocking adenosine A1 receptors with 8-cyclopentyltheophylline (8-CPT) (2 µM). (B) Example recording from a pyramidal cell where the
application of 8CPT (2 µM) induced a large and rapid depolarizing shift in the membrane potential. The membrane potential remained depolarized for a long period
(over 20 min). (C) The mean change (summarized for 8 cells, P < 0.001) in membrane potential produced by blocking A1 receptors with 8CPT in resting conditions
(normal aCSF) and in Ca2+ free aCSF.
break-down product inosine. If adenosine is released into the
extracellular space and then metabolized to inosine, a signal
directly produced by adenosine would be expected to be faster
than a signal produced by inosine, as it will be slowed by
the intervening metabolism step. In this case the signal on
the ADO biosensor would be faster than that on the INO
biosensor. In contrast, if adenosine is metabolized to inosine
before detection then the rise-time of events on ADO and INO
biosensors will be similar as they are both detecting inosine.
However, this is further complicated as the rise of biosensor
signals also depends on the distance between the purine release
site and the biosensor, with the rise slowed as the distance
increases (Wall and Richardson, 2015). Across all biosensor
recordings (n = 8) there was no consistent difference between
the rise of the signals on ADO and INO biosensors (mean rise
52 ± 10 vs. 55 ± 8 s) suggesting adenosine is metabolized
before detection. In Figure 4B, the first three release-events
on the ADO biosensor have a faster rise than the signals on
the INO biosensor, which is consistent with the detection of
adenosine (as illustrated in the inset). However, the larger
4th event (arrow) has the same rise time on both biosensors
(Figure 4B inset). This suggests that the difference in speed
of rise between signals on the biosensors is likely to result
from the different distances between the release sites and the
biosensors rather than the direct detection of adenosine. These
results suggest that adenosine is metabolized before detection
as observed with other modes of neural activity and that
rise is primarily determined by the distance between release
sites and biosensor. The effects of blocking A1 receptors on
activity (depolarization of membrane potential and increase
firing rate, outlined earlier) confirms that adenosine is released
(since inosine is inactive) and then metabolized before biosensor
detection.
We hypothesize that these spontaneous increases in
extracellular purine concentration are unlikely to arise from the
frequent short depolarizations and associated action potential
firing which is homogeneous and is therefore more likely to
produce the tonic increase in adenosine concentration. Instead
we propose they arise from the occasional periods of enhanced
activity and rapid depolarization blocks that we observed
with the whole cell patch clamp recordings. We have shown
that periods of depolarization, with enhanced firing, can be
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FIGURE 3 | Ca2+-free activity increases the concentration of extracellular adenosine. (A) Trace from an ADO biosensor illustrating that removal of extracellular Ca2+
has no significant effect on the sensitivity to adenosine or baseline current (no slice was present). Adenosine (ADO) (10 µM) was applied during the filled bars.
(B) Diagram showing positioning of electrodes and biosensors in a hippocampal slice. (C) Traces from an adenosine (ADO) biosensor and null sensor both placed in
CA1 approximately 0.5 −1 mm apart. The ADO biosensor trace was deconvolved (Decon) with a time constant of 175 s to separate the release events. Application
of Ca2+-free aCSF resulted in a large current on the ADO biosensor that was not observed on the null sensor. The current had three distinct phases with
spontaneous events (arrows) superimposed on the sustained current in the latter phase. (D) Traces from ADO and INO biosensors during Ca2+ free activity. The
traces are very similar and, given that the ADO biosensor measures both adenosine and inosine, suggests there is little or no adenosine component, which is
consistent with adenosine metabolism before detection.
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FIGURE 4 | Properties of spontaneous adenosine waveforms during established Ca2+-free activity. (A) Traces from an ADO biosensor during established Ca2+ free
activity. The top trace is the raw data showing spontaneous purine-release events, the dotted line shows the baseline current before activity began. The second trace
(decon) shows the deconvolved trace where the slow component of decay (τ = 180 s) of the release events has been removed separating the overlapping pulses and
highlighting the release dynamic’s. The bottom trace (LFP) is the LFP signal which has been extracted from the biosensor current trace. (B) Traces from ADO and INO
biosensors and an extracellular electrode. In this example, spontaneous purine-release events were observed on both ADO and INO biosensors and were weakly
correlated with bursts of activity on the extracellular electrode (dotted lines). (C) Traces from ADO and INO biosensors and an extracellular electrode. In this example
the majority of the release events were observed only on the ADO biosensor and not the INO biosensor. Furthermore the events did not correlate with activity
recorded by the extracellular electrode. The asterisk shows an event measured on both biosensors. Thus in this particular slice most of the events appear localized
near where the ADO biosensor was inserted. (D) Application of 8CPT (2 µM) to block A1 receptors produced a current on the ADO biosensor. (E) Puffing (500 ms
puff duration) of Ca2+ free aCSF with elevated K+ (25 mM) onto area CA1 induced a current on the ADO biosensor which mimicked spontaneous release events.
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localized or can spread across the tissue (Figure 1) which is
consistent with the spatial dynamics of the biosensor signals
(Figure 4). To test this further we carried out manipulations
to increase activity and investigated whether this produces
an increase in extracellular adenosine concentration as we
predicted. Since blocking A1 receptors increases activity
(Figure 2), this should also lead to an increase in extracellular
adenosine concentration. We applied the A1 receptor antagonist
8CPT (2 µM) during established Ca2+ free activity and it
reliably evoked a current on the ADO biosensor (290 ± 91 pA,
equivalent to 1.6 ± 0.32 µM, Figure 4D, n = 5). Since the
periodic depolarizations that are observed are probably due to
waves of extracellular K+ (Bikson et al., 2003), we predicted that
puffing high K+ aCSF onto CA1 should mimic this effect. ACSF
containing 10–25 mM K+ was puffed (500 ms) onto CA1 at
least 30 min after removal of Ca2+. This reliably elicited large
currents on the ADO biosensor (915 ± 350 pA, equivalent to
3.1 ± 0.93 µM, n = 7, Figure 4E) consistent with endogenous
K+ waves releasing adenosine. Puffing zero Ca2+ aCSF with
a standard concentration of K+ (3.1 mM) had no effect on
the biosensor baseline current. This data is consistent with
the spontaneous purine release events arising from periodic
enhanced activity.
Adenosine Release during Established
Ca2+ Free Activity Is Blocked by ENT
Inhibitors
What is the mechanism that links the increase in extracellular
adenosine concentration with the activity induced by removing
Ca2+? It could arise from either the release of ATP and its
subsequent extracellular metabolism or the direct release of
adenosine. The release of ATP by exocytosis would seem unlikely
as there is no extracellular Ca2+ and no currents were observed
on ATP biosensors (n = 6, Figure 5A). To investigate whether
adenosine is directly released we used the ENT inhibitors
NBTI (5 µM) and dipyridamole (10 µM, Wall and Dale,
2013). Experiments were carried out in two ways: first by
pre-incubating slices with NBTI and dipyridamole (20–30 min)
before removing the extracellular Ca2+ (NBTI and dipyridamole
remained present throughout the experiment), and second by
applying NBTI and dipyridamole after removal of extracellular
Ca2+, during phase 3 (∼30 min after Ca2+ removal). In slices
pre-incubated with NBTI and dipyridamole the initial two phases
of adenosine release persisted but the later sustained current
and spontaneous events (phase 3) were either greatly reduced
or abolished (mean inhibition 85 ± 10%, Figures 5B, n = 4). In
a further six slices, NBTI and dipyridamole were applied after
Ca2+ removal during phase 3 and they reduced the amplitude
of both the sustained current (345 ± 40 to 120 ± 20 pA,
mean inhibition 80 ± 8%) and the spontaneous release-events
(reduced from 158 ± 56 to 46 ± 12 pA, mean inhibition
75.6 ± 5% Figure 5C). The effects of NBTI and dipyridamole
were at least partially reversible in wash (Figure 5D, recovered
to 72 ± 5% of control amplitude). This data suggests that
adenosine is directly released via ENTs during established
Ca2+-free activity.
Blocking ENTs Increases Neural Activity
If the adenosine released via ENTs plays a negative feedback
role to supress activity, then it follows that inhibition of
ENTs should enhance neural activity. To test this, NBTI and
dipyridamole were applied during whole-cell patch-clamp
recordings from pyramidal cells in CA1 in Ca2+-free aCSF.
Hippocampal slices were pre-incubated in Ca2+-free aCSF
for at least 30 min before recordings were made, so that the
early increases in extracellular adenosine concentration (not
produced by ENTs) would have dissipated. Application of
NBTI and dipyridamole depolarized CA1 pyramidal cells
(mean depolarization 12 ± 3 mV, which is significantly
(P < 0.001) greater than the amplitude of the short spontaneous
baseline depolarizations 3.5 ± 0.5 mV) and increased
their firing rate and some cells went into depolarization
block (n = 6, Figure 5E). Application of 8CPT, to block
A1 receptors in the presence of NBTI and dipyridamole
further depolarized cells (Figure 5E) showing that some
residual A1-receptor activation was still present. Thus the
adenosine released via ENTs plays a major role in supressing
activity, and when ENTs are inhibited activity is markedly
enhanced.
DISCUSSION
We have shown that adenosine plays a key feedback role in
controlling activity in the hippocampus induced by a reduction
in extracellular Ca2+ concentration. A fall in extracellular
Ca2+ can occur during strong epileptiform activity (Heinemann
et al., 1986) and can initiate seizures in vivo (Feng, 2003)
with hypocalcemia-induced seizures observed clinically (Han
et al., 2015). Adenosine is released into the extracellular space
during Ca2+-free activity to activate A1 receptors, leading to K+
channel activation and the hyperpolarization of pyramidal-cell
membrane potential and reduction in pyramidal-cell firing rates.
Without this endogenous A1-receptor activation, pyramidal
cells become over-excited, fire action potentials at high rates
and can move into long-lasting depolarization block. Once
Ca2+-free activity is established, and Ca2+ dependent process,
like exocytosis are blocked, the major mechanism for increasing
the extracellular concentration of adenosine is the direct release
of adenosine via ENTs. It would be interesting to test whether
the additional adenosine released during ischemia (Pedata et al.,
1993; Frenguelli et al., 2007) and hypoxia (Dale et al., 2000)
induced by the removal of extracellular Ca2+ is also produced
by ENTs.
The Mechanism of the Initial Increase in
Extracellular Adenosine Concentration
The mechanism for the increases in extracellular adenosine
concentration, when slices are initially exposed to Ca2+ free
aCSF, is unclear. These early phases of network activity are
likely to be the result of multiple processes, as some residual
extracellular Ca2+ will still remain, allowing the release of
transmitter from active cells. A barrage of what appeared to be
synaptic potentials was often observed at the start of Ca2+-free
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FIGURE 5 | Adenosine is released via equilbrative nucleoside transporters (ENTs) during established Ca2+-free activity. (A) Traces from ADO and ATP biosensors
during removal of extracellular Ca2+. Although there was a clear increase in the ADO biosensor current, no current was observed on the ATP biosensor. (B) Example
trace from an adenosine biosensor (ADO). Application of Ca2+-free aCSF in the presence of the ENT blockers NBTI (5 µM) and dipyridamole (10 µM) induced the
initial phases of the increase in extracellular adenosine (and metabolite) concentration but the late phase (phase 3) and the spontaneous release events were
abolished (at arrow). (C) Example trace from an ADO biosensor. The spontaneous adenosine release events recorded after 30 min in Ca2+-free aCSF are greatly
reduced in amplitude (∼70%) and there is a fall in baseline current induced by the ENT inhibitors NBTI and dipyridamole. (D) Spontaneous release events recorded
by an ADO biosensor increase in amplitude following wash of NBTI and dipyridamole. (E) Whole-cell patch-clamp recording from a CA1 pyramidal cell following
30 min incubation in Ca2+-free aCSF. Inhibition of ENTs (with NBTI and dipyridamole) induced depolarization and firing of action potentials. Application of 8CPT
(2 µM) to block A1 receptors produced further depolarization and pushed the cell into depolarization block. Perfusing with aCSF containing Ca2+ led to a recovery of
the membrane potential back to control values illustrating the viability of the recorded pyramidal cell.
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activity (Figure 1 inset). These initial phases of increased
extracellular adenosine do not appear to arise from ATP release,
as there was no clear signal measured on ATP biosensors;
however, the rapid metabolism of ATP in the extracellular space,
preventing the direct detection of ATP cannot be excluded.
For example in Klyuch et al. (2012) and Wall and Dale (2013)
∼50% of the adenosine release evoked by electrical stimulation
arose from ATP release, as shown both pharmacologically and
with transgenic mice, and yet in these studies no ATP could
be directly detected using ATP biosensors. It also appears that
the initial increases in extracellular adenosine concentration
are not mediated via ENTs, as they persisted in slices which
have been pre-incubated with the ENT inhibitors NBTI and
dipyridamole.
We have shown that the adenosine released via ENTs plays a
feedback role to control network activity during established Ca2+
free activity (20–30 min Ca2+ free). Thus inhibition of ENTs
enhances the depolarization of CA1 pyramidal cells, increases
their firing rate and pushes some cells into depolarization block.
This is the opposite of what occurs under quiescent conditions
when extracellular Ca2+ is present. Here the block of ENTs
in the hippocampus leads to the accumulation of extracellular
adenosine, activation of A1 receptors and the inhibition of
transmitter release (Dunwiddie and Diao, 1994; Frenguelli et al.,
2007). This illustrates the equilibrative nature of the transporters
which can move adenosine into cells or release it into the
extracellular space depending on the concentration gradient.
Interestingly, the application of 8CPT, to block A1 receptors in
the presence of NBTI and dipyridamole further depolarized cells
(Figure 4E) showing that some residual A1 receptor activation
is still present. This may result from incomplete block of ENTs
or other mechanisms may also contribute to adenosine release.
However it is clear that adenosine release via ENTs plays a major
role in controlling Ca2+ free activity.
Link between Activity and Adenosine
Release
What mechanism links activity in Ca2+-free conditions to the
release of adenosine? The simplest explanation is that prolonged
neuronal depolarization and continual action potential firing
results in the hydrolysis of large amounts of intracellular ATP,
mainly by ion exchange pumps trying to maintain the membrane
potential and extrude Na+ ions. It has been suggested that
up to 55% of brain ATP consumption is used to pump Na+
ions out of cells under physiological conditions (Engel and
Attwell, 2015). Presumably this proportion would be markedly
increased during pathological activity (Engel and Attwell, 2015).
Rapid production of significant amounts of adenosine inside
neurons is likely to directly lead to adenosine efflux down
the concentration gradient via ENTs because neurons do not
express adenosine kinase (Studer et al., 2006) to convert the
adenosine back into AMP. This is supported by the observations
by Sims and Dale (2014) who reported that adenosine release,
in response to AMPA receptor activation, is dependent on
the activity of the Na+/K+ exchange pump. A reduction in
extracellular Na+ concentration or application of ouabain, an
Na+/K+ exchange pump inhibitor, markedly reduced evoked-
adenosine release. In glial cells, large amounts of adenosine
could saturate intracellular adenosine kinase, as it has a relatively
low Km (∼1–2 µM; Phillips and Newsholme, 1979). This
would reduce or reverse the adenosine concentration gradient,
leading to adenosine efflux via ENTs (Brundege and Dunwiddie,
1996).
Once Ca2+-free activity was fully established (∼30 min in
Ca2+ free aCSF) there were periodic spontaneous adenosine
release events which were superimposed on the sustained
extracellular concentration of adenosine (and its metabolites).
Our data suggest that these spontaneous release events arise
following strong activity probably induced by extracellular K+
waves : (1) in some slices these release-events were localized and
only measured on one biosensor and in other slices the events
were measured on both biosensors. This is consistent with the
activity measured fromwhole-cell patch clamp recordings, where
large depolarizations and depolarization blocks, could be either
localized or could be synchronized across cells; (2) Bikson et al.
(2003) showed, using ion sensitive microelectrodes that these
depolarizations were produced by an increase in extracellular
K+. These events could be mimicked by puffing high K+
onto CA1 (in Ca2+ free conditions) and this produced robust
adenosine release; (3) application of 8CPT, to block A1 receptors,
enhanced firing and also produced robust adenosine release and
finally; (4) long lasting membrane potential hyperpolarizations
often followed strong bursts of activity (see Figure 1D for
example) or depolarization blocks, which could be produced by
the released adenosine acting on A1 receptors. The biosensor
waveforms are much longer (decay ∼200 s) than the decay of
the hyperpolarization (decay ∼45 s) but this inconsistently can
be explained by the fact that biosensors detect both adenosine
and its metabolites, with the slow decay the result of diffusion
of purines out of the slice (Wall and Richardson, 2015).
An alternative explanation for the hyperpolarizations is the
activation of Na+ or ATP dependent K+ channels (but not Ca2+-
dependent K+ channels). This could potentially be tested by
applying a cocktail of K+ channel blockers, since blocking of A1
receptors leads to marked depolarization, increased firing and in
many cells depolarization block. These bursts of increased neural
activity probably represent escape from adenosine suppression
control. These may occur because the waves of increased
extracellular K+ concentration weaken the hyperpolarizing effect
of GIRK activation (as the outward K+ gradient will be reduced
or reversed).
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